Biologic Drugs With Chemical Structure: Antibodies, Monoclonal, Humanized
Biologic Drugs With Chemical Structure: Antibodies, Monoclonal, Humanized
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | PRAXBIND | idarucizumab | Injection | 761025 | 2015-10-16 | ⤷ Start Trial | ⤷ Start Trial |
| Boehringer Ingelheim Pharmaceuticals, Inc. | PRAXBIND | idarucizumab | Injection | 761025 | 2015-10-16 | 8,486,398 | ⤷ Start Trial |
| Boehringer Ingelheim Pharmaceuticals, Inc. | PRAXBIND | idarucizumab | Injection | 761025 | 2015-10-16 | 9,034,822 | ⤷ Start Trial |
| Boehringer Ingelheim Pharmaceuticals, Inc. | PRAXBIND | idarucizumab | Injection | 761025 | 2015-10-16 | 84,863,988,486,398 | ⤷ Start Trial |
| Boehringer Ingelheim Pharmaceuticals, Inc. | PRAXBIND | idarucizumab | Injection | 761025 | 2015-10-16 | 90,348,229,034,822 | ⤷ Start Trial |
| Genentech, Inc. | TECENTRIQ | atezolizumab | Injection | 761034 | 2016-05-18 | ⤷ Start Trial | ⤷ Start Trial |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Patent Expiration |
